Hims & Hers Stock Dips: GLP-1 Sales Miss Expectations

Hims & Hers stock plummets as GLP-1 sales falter. Regulatory pressures mount, but what's next for telehealth's weight-loss boom? Click...

05/08/2025

1 views

Generic Semaglutide in Canada: Weight Loss Revolution

Hims & Hers brings generic semaglutide to Canada, promising affordable weight loss solutions. But how will this change lives? Click...

09/07/2025

2 views

A new at-home cervical cancer test is changing women’s healthcare. Easy, accurate, and accessible—could this be the future of preventive...

09/05/2025

0 views

Struggling to access mental health care? Virtual therapy is changing the game with affordability and ease. Curious how it works?...

30/04/2025

0 views

Telehealth stocks are at a crossroads post-GLP-1 shortage. What’s driving the shift, and where’s the market headed? Dive into the...

29/04/2025

0 views